Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Mar 6, 2025
- Accession no.
- 0001447362-25-000038
- Filed
- Mar 6, 2025
- Trade date
- Mar 4, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 2 derivative transactions. Open-market sales total $118.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Common Stock | MOption exerciseAcquired | +31,109 | –F1 | – | 111,927 | Direct | |
| Mar 4, 2025 | Common Stock | FTax withholdingDisposed | −7,576 | $22.23 | −$168,414.48 | 104,351 | Direct | |
| Mar 4, 2025 | Common Stock | SSaleDisposed | −1,247 | $20.86F3 | −$26,012.42 | 103,104 | Direct | |
| Mar 4, 2025 | Common Stock | SSaleDisposed | −2,022 | $20.86F3 | −$42,178.92 | 69,059 | Indirect | |
| Mar 4, 2025 | Common Stock | SSaleDisposed | −1,739 | $20.86F3 | −$36,275.54 | 58,834 | Indirect | |
| Mar 4, 2025 | Common Stock | SSaleDisposed | −172 | $20.86F3 | −$3,587.92 | 4,938 | Indirect | |
| Mar 4, 2025 | Common Stock | SSaleDisposed | −169 | $20.86F3 | −$3,525.34 | 4,935 | Indirect | |
| Mar 4, 2025 | Common Stock | SSaleDisposed | −169 | $20.86F3 | −$3,525.34 | 4,935 | Indirect | |
| Mar 4, 2025 | Common Stock | SSaleDisposed | −169 | $20.86F3 | −$3,525.34 | 4,935 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Common Stock | AGrant or awardAcquired | +111,948 | $0.00 | $0 | 111,948 | Direct | |
| Mar 4, 2025 | Common Stock | MOption exerciseDisposed | −31,109 | $0.00 | $0 | 93,328 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $20.565 to $21.130, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.